Roche Group

GPTKB entity

Properties (59)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Genentech_in_2009
Spark_Therapeutics_in_2019
TIB_Molbiol_in_2019
gptkbp:advertising Katrin_Schick
Miriam_Stankovic
gptkbp:awards numerous industry awards
gptkbp:CEO gptkb:Severin_Schwan
gptkbp:clinicalTrials in infectious diseases
conducts thousands annually
for chronic diseases
focus on personalized healthcare
in neurology
for COVID-19 treatments
for cancer therapies
for rare diseases
in immunology
in oncology
gptkbp:competitors gptkb:Johnson_&_Johnson
gptkb:Pfizer
gptkb:Merck_&_Co.
Novartis
gptkbp:divisions pharmaceutical division
diagnostics division
gptkbp:employees around 100,000 (2020)
gptkbp:founded 1896
gptkbp:founder gptkb:Fritz_Hoffmann-La_Roche
gptkbp:global_presence operates in over 100 countries
gptkbp:headCoach gptkb:Thomas_Schinecker
gptkbp:headquarters gptkb:Basel,_Switzerland
https://www.w3.org/2000/01/rdf-schema#label Roche Group
gptkbp:industry pharmaceuticals
gptkbp:innovation focus on innovative medicines
gptkbp:investmentFocus approximately 11 billion CHF (2020)
gptkbp:leadership diverse leadership team
gptkbp:market approximately 200 billion CHF (2021)
global pharmaceutical market
gptkbp:operations gptkb:Rafael_M._L._de_la_Torre
gptkbp:partnerships collaborations with universities
with global health organizations
alliances with biotech companies
with_WHO
gptkbp:patentCitation holds numerous patents in pharmaceuticals
gptkbp:philanthropy gptkb:Roche_Foundation
gptkbp:products biopharmaceuticals
diagnostics
gptkbp:research gptkb:Levi_Garraway
gptkbp:research_focus neurology
oncology
infectious diseases
immunology
gptkbp:revenue 63.3 billion CHF (2020)
gptkbp:social_responsibility commitment to diversity and inclusion
commitment to environmental sustainability
commitment to access to medicines
gptkbp:stockExchange gptkb:SIX_Swiss_Exchange
gptkbp:subsidiary gptkb:Genentech
gptkb:Roche_Diagnostics
gptkbp:sustainability_initiatives environmental responsibility programs